P.M.J.J. Berns

868 total citations
13 papers, 714 citations indexed

About

P.M.J.J. Berns is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, P.M.J.J. Berns has authored 13 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in P.M.J.J. Berns's work include HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (3 papers) and Cancer Treatment and Pharmacology (3 papers). P.M.J.J. Berns is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (3 papers) and Cancer Treatment and Pharmacology (3 papers). P.M.J.J. Berns collaborates with scholars based in Netherlands and Belgium. P.M.J.J. Berns's co-authors include John A. Foekens, J.G.M. Klijn, Paul Schmitz, J.G.M. Klijn, J. Alexieva-Figusch, M. Bontenbal, M.E.L. van der Burg, C. J. Rodenburg, S.C. Henzen‐Logmans and Wim L.J. van Putten and has published in prestigious journals such as Endocrine Reviews, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

P.M.J.J. Berns

13 papers receiving 687 citations

Peers

P.M.J.J. Berns

ONCOL

RNMI

PRM

W. H. Miller United States

Slamon Dj United States

Duen‐Hwa Yan United States

Piera Maggiora Italy

John Cairns United Kingdom

CL Arteaga United States

Rena D. Callahan United States

P.M. Wencyk United Kingdom

Andrew Berchuck United States

Per-Olof Malmström Sweden

W. H. Miller United States

P.M.J.J. Berns

486 ×1.0

ONCOL

283 ×1.0

88 ×0.5

104 ×0.7

RNMI

166 ×1.1

PRM

Citations per year, relative to P.M.J.J. Berns P.M.J.J. Berns (= 1×) peers W. H. Miller

Countries citing papers authored by P.M.J.J. Berns

Since Specialization

Citations

This map shows the geographic impact of P.M.J.J. Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M.J.J. Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M.J.J. Berns more than expected).

Fields of papers citing papers by P.M.J.J. Berns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M.J.J. Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M.J.J. Berns. The network helps show where P.M.J.J. Berns may publish in the future.

Co-authorship network of co-authors of P.M.J.J. Berns

This figure shows the co-authorship network connecting the top 25 collaborators of P.M.J.J. Berns. A scholar is included among the top collaborators of P.M.J.J. Berns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M.J.J. Berns. P.M.J.J. Berns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Timmermans, A. Mieke, Maxime P. Look, Marion E. Meijer‐van Gelder, et al.. (2014). High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer. Annals of Oncology. 25(11). 2185–2190. 46 indexed citations

Zaal, Afra, Wouter J. Peyrot, P.M.J.J. Berns, et al.. (2012). Genomic aberrations relate early and advanced stage ovarian cancer. Cellular Oncology. 35(3). 181–188. 6 indexed citations

Berns, P.M.J.J., Marleen Kok, Fred C.G.J. Sweep, et al.. (2009). CYP-2C19*2 Predicts Favorable Outcome of Tamoxifen Treatment for Advanced Breast Cancer.. Cancer Research. 69(24_Supplement). 4036–4036. 1 indexed citations

Berns, P.M.J.J., Lambert C. J. Dorssers, & J.A. Foekens. (2001). Molecular classification of tamoxifen-responsive and -resistant breast carcinomas by gene expression profiling. 2 indexed citations

Klijn, J.G.M., P.M.J.J. Berns, M. Bontenbal, & John A. Foekens. (1993). Growth Factors. Annals of the New York Academy of Sciences. 698(1). 85–101. 9 indexed citations

Klijn, J.G.M., P.M.J.J. Berns, Wim L.J. van Putten, et al.. (1993). Critical Review of Growth Factors as Clinical Tools in Primary and Metastatic Breast Cancer. Recent results in cancer research. 127. 77–88. 2 indexed citations

Berns, P.M.J.J., et al.. (1993). The prognostic value of epidermal growth factor receptors determined both by immunohistochemistry and ligand binding assay, in primary epithelial ovarian cancer (OC). European Journal of Cancer. 29. S53–S53. 1 indexed citations

Henzen‐Logmans, S.C., M.E.L. van der Burg, John A. Foekens, et al.. (1992). Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study. Journal of Cancer Research and Clinical Oncology. 118(4). 303–307. 16 indexed citations

Klijn, J.G.M., P.M.J.J. Berns, M. Bontenbal, J. Alexieva-Figusch, & John A. Foekens. (1992). Clinical breast cancer, new developments in selection and endocrine treatment of patients. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 211–221. 37 indexed citations

10.

Klijn, J.G.M., P.M.J.J. Berns, Paul Schmitz, & John A. Foekens. (1992). The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*. Endocrine Reviews. 13(1). 3–17. 494 indexed citations

11.

Klijn, J.G.M., Buddy Setyono-Han, G.H. Bakker, et al.. (1990). Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: Preclinical and clinical studies. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1089–1095. 21 indexed citations

12.

Foekens, John A., Wim L.J. van Putten, Henk Portengen, et al.. (1990). Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 815–821. 52 indexed citations

13.

Blankenstein, Marinus A., P.M.J.J. Berns, G. Blaauw, E. Mulder, & J.H.H. Thijssen. (1986). Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor.. PubMed. 46(8 Suppl). 4268s–4270s. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact